Kala Pharmaceuticals, Inc. Contracts & Agreements

68 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Registration Rights Agreement, dated December 29, 2024, by and among KALA BIO, Inc. and the parties thereto
Registration Rights Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
2024
Securities Purchase Agreement, dated December 29, 2024, by and among KALA BIO, Inc. and the purchasers party thereto
Purchase Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
2024
Securities Purchase Agreement, dated June 26, 2024, by and among KALA BIO, Inc. and the purchasers party thereto
Purchase Agreements
Kala Pharmaceuticals, Inc.
2024
Registration Rights Agreement, dated June 26, 2024, by and among KALA BIO, Inc. and the parties thereto
Registration Rights Agreements
Kala Pharmaceuticals, Inc.
2024
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
Kala Pharmaceuticals, Inc.
2024
Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350
Kala Pharmaceuticals, Inc.
2024
Securities Purchase Agreement, dated March 25, 2024, by and among KALA BIO, Inc. and the purchasers party thereto
Purchase Agreements
Kala Pharmaceuticals, Inc.
2024
Securities Purchase Agreement, dated December 21, 2023, by and among KALA BIO, Inc. and the purchasers party thereto
Purchase Agreements
Kala Pharmaceuticals, Inc.
2023
Form of Incentive Stock Option Agreement under Amended and Restated 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Kala Pharmaceuticals, Inc.
2023
Form of Non-Qualified Option Agreement under Amended and Restated 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Kala Pharmaceuticals, Inc.
2023
Form of Non-Employee Director Restricted Stock Unit Award under Amended and Restated 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Kala Pharmaceuticals, Inc.
2023
Form of Non-Employee Director Deferred Restricted Stock Unit Award under Amended and Restated 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Kala Pharmaceuticals, Inc.
2023
Form of Employee Restricted Stock Unit Award under Amended and Restated 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Kala Pharmaceuticals, Inc.
2023
Form of Inducement Restricted Stock Unit Agreement
Stock Agreements
Kala Pharmaceuticals, Inc.
2023
Fourth Amendment to Loan and Security Agreement, dated August 1, 2023, by and among the Registrant, Combangio, Inc. and Oxford Finance LLC, as collateral agent and lender
Loan Agreements
Kala Pharmaceuticals, Inc.
2023
Fifth Amendment to Loan and Security Agreement, dated August 2, 2023, by and among the Registrant, Combangio, Inc. and Oxford Finance LLC, as collateral agent and lender
Loan Agreements
Kala Pharmaceuticals, Inc.
2023
Specimen Stock Certificate evidencing the shares of common stock
Stock Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
2023
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
Kala Pharmaceuticals, Inc.
2023
Registration Rights Agreement, dated March 2, 2023, by and among the Registrant and the persons party thereto
Registration Rights Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Open Market Sale AgreementSM, dated as of January 19, 2023, by and between Kala Pharmaceuticals, Inc. and Jefferies LLC
Kala Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Third Amendment to Loan and Security Agreement, dated December 27, 2022, by and among Kala Pharmaceuticals, Inc., Combangio, Inc. and Oxford Finance LLC, as collateral agent and...
Loan Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
2022
Form of Series E Preferred Stock Certificate
Stock Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
2022
Securities Purchase Agreement, dated November 28, 2022, by and among Kala Pharmaceuticals, Inc. and the purchasers party thereto
Purchase Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
First Amendment to Loan and Security Agreement, dated November 15, 2021, by and among the Registrant, Combangio, Inc. and Oxford Finance LLC, as collateral agent and lender
Loan Agreements
Kala Pharmaceuticals, Inc.
2022
Second Amendment to Loan and Security Agreement, dated May 21, 2022, by and among the Registrant, Combangio, Inc. and Oxford Finance LLC, as collateral agent and lender
Loan Agreements
Kala Pharmaceuticals, Inc.
2022
Asset Purchase Agreement, by and between Kala Pharmaceuticals, Inc., Alcon Pharmaceuticals Ltd. and Alcon Vision, LLC
Purchase Agreements
Kala Pharmaceuticals, Inc.
2022
Exclusive License Agreement, dated October 11, 2019, by and between Combangio, Inc. and The Board of Trustees of the Leland Stanford Junior University
License Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
CA
2022
Amendment No. 4 to Commercial Supply Agreement, effective January 6, 2021, by and between the Registrant and Woodstock Sterile Solution, Inc
Supply Agreements
Kala Pharmaceuticals, Inc.
2022
First Amendment to Lease Termination Agreement, dated December 22, 2021, by and between the Registrant and Columbia Massachusetts Arsenal Office Properties, LLC
Lease Agreements
Kala Pharmaceuticals, Inc.
2022
Agreement and Plan of Merger, dated as of November 15, 2021, by and among Kala Pharmaceuticals, Inc., Ceres Merger Sub, Inc., Combangio, Inc. and, solely in its capacity as...
Merger Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Lease Termination Agreement, dated November 12, 2021, by and between Kala Pharmaceuticals, Inc. and Columbia Massachusetts Arsenal Office Properties, LLC
Lease Agreements
Kala Pharmaceuticals, Inc.
2021
Exclusive License Agreement, dated November 10, 2009, by and between the Registrant and The Johns Hopkins University, as amended by the First Amendment dated November 19, 2012,...
License Agreements
Kala Pharmaceuticals, Inc.
2021
Settlement and License Agreement, dated October 24, 2014, by and between the Registrant and GrayBug, LLC
Settlement Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
Loan and Security Agreement, dated May 4, 2021, by and among Kala Pharmaceuticals, Inc. and Oxford Finance LLC, as collateral agent and lender
Loan Agreements
Kala Pharmaceuticals, Inc.
2021
Third Amended and Restated Registration Rights Agreement of the Registrant dated April 4, 2016, as amended by Amendment No. 1 dated December 13, 2017, of the Registrant
Registration Rights Agreements
Kala Pharmaceuticals, Inc.
2021
Amendment No. 1 to Amended and Restated Master Services Agreement, dated August 25, 2020 by and between the Registrant and Altasciences company (formerly Alliance Contract Pharma,...
Services Agreements
Kala Pharmaceuticals, Inc.
2021
Amendment No. 3 to Commercial Supply Agreement, dated December 11, 2020, by and between the Registrant and Catalent Pharma Solutions, LLC
Supply Agreements
Kala Pharmaceuticals, Inc.
2021
Fifth Amendment to Exclusive License Agreement, date July 6, 2020, by and between the Johns Hopkins University and the Registrant
License Agreements
Kala Pharmaceuticals, Inc.
2020
Form of Employee Restricted Stock Unit Award under 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Amendment No. 2 to Commercial Supply Agreement, dated March 27, 2020, by and between the Registrant and Catalent Pharma Solutions, LLC
Supply Agreements
Kala Pharmaceuticals, Inc.
2020
Form of Non-Employee Director Restricted Stock Unit Award under 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Kala Pharmaceuticals, Inc.
2020
Form of Non-Employee Director Deferred Restricted Stock Unit Award under 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Kala Pharmaceuticals, Inc.
2020
Underwriting Agreement, dated March 10, 2020, by and among Kala Pharmaceuticals, Inc., J.P. Morgan Securities LLC, BofA Securities, Inc. and Jefferies LLC, as representatives of...
Underwriting Agreements
Kala Pharmaceuticals, Inc.
2020
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
Kala Pharmaceuticals, Inc.
2020
Amended and Restated 2017 Employee Stock Purchase Plan
Stock Agreements
Kala Pharmaceuticals, Inc.
2019
Amended and Restated 2017 Employee Stock Purchase Plan
Stock Agreements
Kala Pharmaceuticals, Inc.
2019
Form of Amendment to Offer Letters
Kala Pharmaceuticals, Inc.
Pharmaceuticals
MA
2019
Form of Inducement Grant Stock Option Agreement
Stock Agreements
Kala Pharmaceuticals, Inc.
2018
Underwriting Agreement, dated October 2, 2018, by and among Kala Pharmaceuticals, Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and...
Underwriting Agreements
Kala Pharmaceuticals, Inc.
2018
Fourth Amendment to Exclusive License Agreement, dated June 22, 2018, by and between The Johns Hopkins University and the Registrant
License Agreements
Kala Pharmaceuticals, Inc.
2018
Form of Inducement Grant Stock Option Agreement
Stock Agreements
Kala Pharmaceuticals, Inc.
2018
Letter Agreement, dated March 25, 2018, by and between the Registrant and Eric Trachtenberg
Kala Pharmaceuticals, Inc.
Pharmaceuticals
MA
2018
Loan and Security Agreement, dated November 20, 2014, by and between the Registrant and Square 1 Bank, as amended
Loan Agreements
Kala Pharmaceuticals, Inc.
2018
Letter Agreement, dated November 6, 2017, by and between the Registrant and Todd Bazemore
Kala Pharmaceuticals, Inc.
Pharmaceuticals
MA
2018
Amended and Restated Master Services Agreement, dated October 4, 2017, by and between the Registrant and Alliance Contract Pharma, LLC
Services Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
MA
2018
Amendment No. 1 to Commercial Supply Agreement, dated February 16, 2018, by and between the Registrant and Catalent Pharma Solutions, LLC
Supply Agreements
Kala Pharmaceuticals, Inc.
2018
Amended and Restated Letter Agreement, dated September 10, 2015, by and between the Registrant and Mark Iwicki, as amended by the First Amendment, dated September 28, 2017
Kala Pharmaceuticals, Inc.
Pharmaceuticals
MA
2017
KALA PHARMACEUTICALS, INC. [] Shares of Common Stock Underwriting Agreement
Underwriting Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
NY
2017
KALA PHARMACEUTICALS, INC. 2017 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
DE
2017
Kala Pharmaceuticals, Inc. 2017 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
DE
2017
KALA PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Kala Pharmaceuticals, Inc.
2017
KALA PHARMACEUTICALS, INC. NON-QUALIFIED OPTION AGREEMENT
Kala Pharmaceuticals, Inc.
2017
KALA PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
DE
2017
KALA PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT April 6, 2016
Registration Rights Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
DE
2017
HANES NEWCO, INC. 2009 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Kala Pharmaceuticals, Inc.
Pharmaceuticals
DE
2017
KALA PHARMACEUTICALS, INC. Stock Option Grant Notice Stock Option Grant under the Companys 2009 Employee, Director and Consultant Equity Incentive Plan
Bonus & Incentive Agreements
Kala Pharmaceuticals, Inc.
2017
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. EXCLUSIVE LICENSE AGREEMENT BETWEEN THE JOHNS...
License Agreements
Kala Pharmaceuticals, Inc.
2017
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Kala Pharmaceuticals, Inc.
Pharmaceuticals
NY
2017